Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology? 

Slides:



Advertisements
Similar presentations
Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?  Micah.
Advertisements

Nicole Banks, M. D. , George Patounakis, M. D. , Ph. D
Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?  Matthew.
Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,
Justin J. Nork, D. O. , Jonathan H. Berger, M. D. , Donald S. Crain, M
Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers 
Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada  Natalie Dayan, M.D., Andrea Lanes, M.Sc.,
Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location  Micah.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W
Infertility evaluation and treatment among women in the United States
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Continued existence of significant disparities in the technical practices of sperm morphology assessment and the clinical implications: results of a French.
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community 
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF  John Y Phelps, M.D., Adam S Levine,
Live birth of twins derived from zona-free oocytes
Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis  Juan Wen, B.S., Jie Jiang, B.S.,
Management of the first in vitro fertilization cycle for unexplained infertility: a cost- effectiveness analysis of split in vitro fertilization-intracytoplasmic.
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
Intracytoplasmic sperm injection in partial globozoospermia
Predictive value of the hemizona assay for pregnancy outcome in patients undergoing controlled ovarian hyperstimulation with intrauterine insemination 
Sherman J. Silber, M.D.  Fertility and Sterility 
Use of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with cryptozoospermia: a meta-analysis  Nikita Abhyankar, M.B.ChB.,
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles  Eva R. Groenewoud, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
From partner's desk to iPad
Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?  Mae Wu Healy, D.O., George Patounakis, M.D.,
Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized.
Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?  Heather Cook, M.D., Kathleen Brennan,
Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained.
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis  Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,
Ongoing twin pregnancy after rescue intracytoplasmic sperm injection of unfertilized abnormal oocytes  Navid Esfandiari, D.V.M., Ph.D., H.C.L.D., E. Anne.
Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles  Nicolás Garrido,
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Trends and outcomes of gestational surrogacy in the United States
Poor sperm quality affects clinical outcomes of intracytoplasmic sperm injection in fresh and subsequent frozen–thawed cycles: potential paternal effects.
Fertility and Sterility
A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 
Zsolt P. Nagy, M. D. , Ph. D. , Laura F. Rienzi, Ph. D. , Filippo M
Complex chromosome abnormality in patients with in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)  S.P. Weng, T.C.J. Wu, S.P. Kang,
Fertility and Sterility and impact factor
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection  William.
Fertility and Sterility: an evaluation
Temporal and geospatial trends in male factor infertility with assisted reproductive technology in the United States from 1999–2010  Anobel Y. Odisho,
Physical health at 5.5 years of age of term-born singletons after intracytoplasmic sperm injection: results of a prospective, controlled, single-blinded.
Cognitive development of singletons born after intracytoplasmic sperm injection compared with in vitro fertilization and natural conception  Marjolein.
In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (ICSI) Using Sperm Exposed to Cyclophosphamide Reduces Preimplantation Embryo Development.
Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination  Deirdre A.
Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome  Mehdi Benchaib, M.D., Ph.D., Jacqueline.
Use of the egg-share model to investigate the paternal influence on fertilization and embryo development after in vitro fertilization and intracytoplasmic.
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B
Genetic evaluation procedures at sperm banks in the United States
Thin endometrial stripe does not affect likelihood of achieving pregnancy in clomiphene citrate/intrauterine insemination cycles  Albert Asante, M.D.,
Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles  Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.
Experience with a patient-friendly, mandatory, single-blastocyst transfer policy: the power of one  John M. Csokmay, M.D., Micah J. Hill, D.O., Rebecca.
Are sperm DNA fragmentation, hyperactivation, and hyaluronan-binding ability predictive for fertilization and embryo development in in vitro fertilization.
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles 
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous?  John M. Norian, M.D., Eric D. Levens,
The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review.
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated.
Presentation transcript:

Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology?  Greene Donald Royster, M.D., Kavitha Krishnamoorthy, M.D., John M. Csokmay, M.D., Belinda J. Yauger, M.D., Rebecca J. Chason, M.D., Alan H. DeCherney, M.D., Erin F. Wolff, M.D., Micah J. Hill, D.O.  Fertility and Sterility  Volume 106, Issue 2, Pages 363-370.e3 (August 2016) DOI: 10.1016/j.fertnstert.2016.04.023 Copyright © 2016 Terms and Conditions

Figure 1 Greater than efficiency curves evaluating the effect of estradiol (E2) on adverse placental outcomes. The occurrence of adverse outcomes was calculated for each E2 threshold in increments of 500 pg/mL. (A) All cycles in the study. (B) All cycles in the study broken down into intracytoplasmic sperm injection (ICSI) versus IVF. Fertility and Sterility 2016 106, 363-370.e3DOI: (10.1016/j.fertnstert.2016.04.023) Copyright © 2016 Terms and Conditions

Figure 2 Receiver operating characteristic (ROC) curves evaluating the ability of peak E2 measurements to predict adverse placental outcomes in (A) all adverse outcomes, (B) hypertensive disorders, and (C) growth disorders. Fertility and Sterility 2016 106, 363-370.e3DOI: (10.1016/j.fertnstert.2016.04.023) Copyright © 2016 Terms and Conditions

Supplemental Figure 1 Greater than efficiency curves evaluating the effect of estradiol (E2) on adverse placental outcomes. The occurrence of various adverse outcomes was calculated for each E2 threshold in increments of 500 pg/mL. Fertility and Sterility 2016 106, 363-370.e3DOI: (10.1016/j.fertnstert.2016.04.023) Copyright © 2016 Terms and Conditions

Supplemental Figure 2 Greater than efficiency curves evaluating the effect of estradiol (E2) on adverse placental outcomes in patients undergoing intracytoplasmic sperm injection (ICSI) without male factor infertility (−MF) and with male factor infertility (+MF). The occurrence of adverse outcomes was calculated for each E2 threshold in increments of 500 pg/mL. Fertility and Sterility 2016 106, 363-370.e3DOI: (10.1016/j.fertnstert.2016.04.023) Copyright © 2016 Terms and Conditions